FDA — Food and Drug Administration
Supports regulatory science, medical product safety, food safety, and public health innovation in the United States.
The FDA, short for Food and Drug Administration, is a U.S. federal agency within HHS that regulates foods, human and animal drugs, biologics, medical devices, and tobacco products. In FY2023 it awarded $273 million in federal assistance, so its grant activity sits alongside its much larger regulatory role.
Its funded work runs through grants, cooperative agreements, and procurement contracts. Core channels include the Orphan Products grants program, MUMS animal drug grants, Pediatric Device Consortia, Centers of Excellence in Regulatory Science and Innovation, and tobacco regulatory science awards. The structured record places biotechnology, medtech, AI infrastructure, and materials in its funding scope, with award sizes ranging from smaller research grants to a $50 million CERSI cooperative agreement cap and a $250,000 cap for MUMS animal drug grants.
FDA is a strong fit for groups working on regulatory science, rare disease therapeutics, pediatric devices, or animal health products that sit close to approval and evidence-generation pathways. Its funding is tightly tied to statutory mandates and HHS priorities, so applicants do best when they match a clear public-health or regulatory problem to a program with a defined scientific endpoint.